Your browser is no longer supported. Please, upgrade your browser.
Settings
OSUR OraSure Technologies, Inc. daily Stock Chart
OSUR [NASD]
OraSure Technologies, Inc.
Index- P/E34.86 EPS (ttm)0.35 Insider Own3.00% Shs Outstand57.65M Perf Week11.69%
Market Cap699.29M Forward P/E50.12 EPS next Y0.24 Insider Trans-32.56% Shs Float55.71M Perf Month9.48%
Income19.70M PEG1.74 EPS next Q0.18 Inst Own80.40% Short Float2.83% Perf Quarter34.93%
Sales128.20M P/S5.45 EPS this Y142.90% Inst Trans-1.70% Short Ratio1.96 Perf Half Y42.87%
Book/sh3.33 P/B3.64 EPS next Y-35.81% ROA9.90% Target Price11.50 Perf Year77.08%
Cash/sh2.07 P/C5.87 EPS next 5Y20.00% ROE11.40% 52W Range5.57 - 12.28 Perf YTD38.15%
Dividend- P/FCF38.01 EPS past 5Y31.00% ROI10.60% 52W High-1.22% Beta1.61
Dividend %- Quick Ratio8.30 Sales past 5Y9.40% Gross Margin68.70% 52W Low117.77% ATR0.39
Employees325 Current Ratio9.00 Sales Q/Q9.60% Oper. Margin15.90% RSI (14)70.60 Volatility3.00% 2.99%
OptionableYes Debt/Eq0.00 EPS Q/Q54.40% Profit Margin15.40% Rel Volume1.90 Prev Close12.06
ShortableYes LT Debt/Eq0.00 EarningsFeb 08 AMC Payout0.00% Avg Volume803.23K Price12.13
Recom1.70 SMA206.02% SMA5018.33% SMA20044.46% Volume1,528,267 Change0.62%
Feb-09-17Upgrade Raymond James Mkt Perform → Outperform
Jun-13-16Downgrade Raymond James Outperform → Mkt Perform
Nov-05-15Reiterated Mizuho Buy $12 → $8
May-07-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-23-15Reiterated Mizuho Buy $10 → $12
Jun-12-14Reiterated Canaccord Genuity Buy $10 → $11
Jun-11-14Reiterated Mizuho Buy $9 → $10
Dec-21-12Initiated Mizuho Buy $9
Aug-08-12Upgrade Barrington Research Mkt Perform → Outperform $12.50
Jul-05-12Downgrade Barrington Research Outperform → Mkt Perform
Mar-27-12Initiated JMP Securities Mkt Outperform $15
Mar-21-12Upgrade MLV & Co Hold → Buy $11 → $13
Feb-09-12Downgrade MLV & Co Buy → Hold $11
Jul-01-11Resumed Barrington Research Outperform $10
Nov-30-10Initiated Barrington Research Outperform $8
Nov-16-10Initiated Canaccord Genuity Buy $8
Nov-17-09Upgrade Needham Hold → Buy $5.50
May-04-09Reiterated FBR Capital Markets Mkt Perform $17 → $16
Jun-20-08Downgrade Needham Buy → Hold
May-07-08Reiterated Susquehanna Financial Positive $12 → $10
Mar-24-17 09:30AM  Zacks Industry Outlook Highlights: Quidel, OraSure Technologies, ResMed, Inogen and Masimo
Mar-22-17 09:30AM  Today's Research Reports on Stocks to Watch: OraSure Technologies and Sunshine Heart Accesswire
08:25AM  OraSure Technologies (OSUR) In Focus: Stock Jumps 8.4%
Mar-21-17 05:00PM  Why Chipotle Mexican Grill, Sprouts Farmers Markets, and OraSure Technologies Jumped Today at Motley Fool +8.36%
Mar-20-17 06:36PM  OraSure Technologies and John B. Sanfilippo & Son Set to Join S&P SmallCap 600 PR Newswire
09:30AM  Zacks.com featured highlights: American Woodmark, Heska, OraSure Technologies, Pioneer Natural Resources and Advanced Energy Industries
Mar-18-17 01:04PM  ORASURE TECHNOLOGIES INC Financials
Mar-17-17 11:44AM  Top 5 Efficient Stocks to Buy Right Now
11:30AM  Medical Device Company's Growth Driven By One-Time Gain at Forbes
Mar-14-17 04:13PM  ORASURE TECHNOLOGIES INC Files SEC form 10-K, Annual Report
Mar-10-17 09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
Mar-02-17 09:30AM  Zacks.com featured highlights: Teradyne, Advanced Energy Industries, Lululemon Athletica, Bovie Medical and OraSure Technologies
Mar-01-17 08:46AM  5 Best Efficient Stocks to Buy in March
06:00AM  OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement GlobeNewswire
Feb-27-17 10:27AM  Top Ranked Momentum Stocks to Buy for February 27th
06:00AM  OraSure Technologies to Present at the Raymond James 38th Annual Institutional Investors Conference GlobeNewswire
Feb-24-17 09:19AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
06:00AM  OraSure Technologies Announces Director Retirement GlobeNewswire
Feb-17-17 08:39AM  Surging Earnings Estimates Signal Good News for OraSure (OSUR)
Feb-16-17 09:30AM  Zacks.com featured highlights: Rush Enterprises, Louisiana-Pacific, Alliance Resource Partners, Teradyne and OraSure Technologies
Feb-15-17 11:25AM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-13-17 09:30AM  Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies
Feb-10-17 05:00PM  OraSure Technologies, Inc.: Leads amongst peers with strong fundamentals
02:04PM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
08:30AM  Want to Gain from Relative Price Strength? 5 Stocks to Buy
Feb-09-17 01:35PM  Why OraSure Technologies, Inc. Leaped Higher Today at Motley Fool +18.53%
11:45AM  3 Quiet Earnings Reports Making the Biggest Moves on Thursday
06:34AM  OraSure upgraded by Raymond James
Feb-08-17 10:02PM  Edited Transcript of OSUR earnings conference call or presentation 8-Feb-17 10:00pm GMT
05:11PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
05:00PM  OraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today
04:32PM  OraSure posts 4Q profit
04:00PM  OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results GlobeNewswire
07:07AM  Q4 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET
Feb-06-17 07:55AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA GlobeNewswire
Feb-01-17 07:26AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : February 1, 2017
Jan-31-17 09:38AM  AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Lag
Jan-30-17 09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
08:20AM  Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates
Jan-27-17 08:38AM  Abaxis (ABAX) Q3 Bleak: Earnings In Line, Revenues Miss
08:12AM  Cardiovascular Systems (CSII) Q2 Earnings Better Estimates
Jan-26-17 03:24PM  Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17
09:45AM  Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View
06:43AM  PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues
Jan-25-17 11:00AM  Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
Jan-24-17 08:12AM  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
Jan-23-17 12:16PM  OraSure Technologies, Inc. Value Analysis (NASDAQ:OSUR) : January 23, 2017
Jan-20-17 08:30AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : January 20, 2017
Jan-11-17 06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Dec-09-16 01:32PM  Is Progenics Pharmaceuticals, Inc. (PGNX) a Good Stock to Buy? at Insider Monkey
Dec-01-16 04:21PM  OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix Win
Nov-29-16 01:29PM  Hedge Funds Are Unsure of OraSure Technologies, Inc. (OSUR) at Insider Monkey
08:22AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program GlobeNewswire
06:00AM  Helix Selects DNA Genoteks Oragene® Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications GlobeNewswire
Nov-28-16 10:00AM  OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire -5.49%
Nov-21-16 06:00AM  OraSure Technologies to Host Analyst Day GlobeNewswire
Nov-15-16 08:40AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
06:00AM  OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors GlobeNewswire
Nov-14-16 07:56AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : November 14, 2016
Nov-09-16 06:00AM  OraSure Technologies to Present at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
Nov-08-16 04:12PM  ORASURE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
12:30PM  ETFs with exposure to OraSure Technologies, Inc. : November 8, 2016
Nov-07-16 10:48AM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
Nov-02-16 09:40PM  Edited Transcript of OSUR earnings conference call or presentation 2-Nov-16 9:00pm GMT
05:33PM  OraSure posts 3Q profit
05:11PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
05:00PM  OraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today
04:00PM  OraSure Announces 2016 Third Quarter Financial Results GlobeNewswire
07:07AM  Q3 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET
Oct-14-16 06:00AM  OraSure Technologies Announces 2017 Annual Meeting Date GlobeNewswire
Oct-12-16 08:43AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : October 12, 2016
06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Oct-08-16 09:22AM  Five Cheap Healthcare Stocks Poised to Explode at Insider Monkey
Oct-06-16 10:00AM  Theranos Exits Lab Business at Forbes
Oct-05-16 04:09PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Sep-30-16 09:30AM  Zacks.com featured highlights: Energy Recovery, Simpson Manufacturing, OraSure Technologies, Provident Financial Services and National Bank Holdings
Sep-19-16 08:36AM  BTIG Downgrades OraSure Technologies To Neutral Citing Valuation
Sep-14-16 09:07AM  5 Stocks Set to Pop on New Analyst Coverage
Sep-07-16 09:30AM  The Zacks Analyst Blog Highlights: Inovio Pharmaceuticals, OraSure Technologies, GlaxoSmithKline, Sanofi and Spectrum Brands
Sep-06-16 08:00AM  6 Drug Stocks in Focus as Zika Virus Fear Spreads
06:00AM  OraSure Technologies to Present at the CL King 14th Annual Best Ideas Conference GlobeNewswire
Sep-05-16 07:04AM  Why Inovio Pharmaceuticals Isn't the Best Zika Stock Right Now at Motley Fool
Sep-02-16 09:29AM  How The Zika Virus Spread While Congress Was Out On Recess
Aug-29-16 04:19PM  Why OraSure Technologies, Inc Rose Today at Motley Fool +10.32%
12:14PM  OraSure (OSUR) Stock Spikes, Upgraded at Stephens
06:00AM  DNA Genoteks OMNIgene® GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome GlobeNewswire
Aug-27-16 10:05AM  FDA Recommends Zika Test for All Blood Donations at 24/7 Wall St.
Aug-25-16 04:15PM  OraSure Technologies, Inc.: Leads amongst peers with strong fundamentals
10:42AM  4 Stocks for Fighting Zika
Aug-24-16 03:55PM  OraSure Gets Zika Contract, Canaccord Raises Price Target +10.57%
03:52PM  OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract
12:10PM  Why OraSure Technologies, Inc is Jumping Today at Motley Fool
10:10AM  Federal Funding Approved for Rapid Zika Virus Test at 24/7 Wall St.
08:45AM  Morning Movers: EXPR, OSUR, LZB, OAS
Aug-23-16 05:25PM  [$$] OraSure Gets U.S. Contract to Hurry Development of Zika Test at The Wall Street Journal
04:00PM  OraSure Awarded Up to $16.6 Million to Advance Rapid Zika Tests GlobeNewswire
Aug-15-16 01:21PM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-08-16 04:38PM  ORASURE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV1/2, OraQuick HIV self-test, OraQuick HCV, OraQuick In-Home HIV test, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, OMNIgene GUT, OMNIgene SPUTUM, PrepIT MAX, OMNIgene VAGINAL, OMNIgene ORAL, PrepIT, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, pharmacogenomics, personalized medicine, microbiome and animal genetics, and academic research markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, retail pharmacies, mass merchandisers, and consumers. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TANG STEPHEN S PHDDirectorMar 21Sale12.002202,64031,748Mar 23 04:41 PM
Celano MichaelDirectorMar 02Option Exercise8.0615,000120,82598,079Mar 06 05:05 PM
Celano MichaelDirectorMar 02Sale12.0015,000180,00083,079Mar 06 05:05 PM
TANG STEPHEN S PHDDirectorMar 02Sale12.026,10073,34631,968Mar 06 05:02 PM
Patrick Charles WDirectorFeb 28Sale11.2713,880156,41460,076Mar 01 03:38 PM
Patrick Charles WDirectorFeb 28Sale11.305,65063,8459,255Mar 02 04:22 PM
Patrick Charles WDirectorFeb 27Sale11.3016,003180,88473,956Mar 01 03:38 PM
SPAIR RONALD HCOO & CFOFeb 16Sale11.1250,000555,780150,063Feb 16 05:33 PM
JERRETT JACK ESVP & General CounselFeb 15Option Exercise6.47107,288694,218163,130Feb 16 05:31 PM
TANG STEPHEN S PHDDirectorFeb 15Option Exercise8.2140,000328,20078,068Feb 16 05:34 PM
TANG STEPHEN S PHDDirectorFeb 15Sale11.0440,000441,75638,068Feb 16 05:34 PM
JERRETT JACK ESVP & General CounselFeb 15Sale11.06107,2881,186,47758,842Feb 16 05:31 PM
SPAIR RONALD HCOO & CFOFeb 14Option Exercise2.812,9268,207118,314Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 14Sale10.659,24898,449109,066Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 13Option Exercise2.8115,79444,302169,860Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 13Sale10.5954,472576,897115,388Feb 15 05:03 PM
KUNA MARK LSVP & ControllerFeb 10Option Exercise6.1964,271397,973127,762Feb 13 04:38 PM
KUNA MARK LSVP & ControllerFeb 10Sale10.7564,271690,78563,491Feb 13 04:38 PM
Michels Douglas APresident & CEOFeb 09Option Exercise4.07193,355786,501961,413Feb 13 04:39 PM
TANG STEPHEN S PHDDirectorFeb 09Sale10.2312,641129,29238,068Feb 13 04:41 PM
Michels Douglas APresident & CEOFeb 09Sale10.21193,3551,974,271768,058Feb 13 04:39 PM
KUNA MARK LSVP & ControllerFeb 09Sale10.0015,000150,00063,491Feb 13 04:38 PM
Celano MichaelDirectorFeb 09Sale10.0610,000100,60083,079Feb 13 04:37 PM
PRINGLE ROGER LDirectorFeb 01Option Exercise8.2815,000124,12550,476Feb 02 07:04 PM
SPAIR RONALD HCOO & CFOFeb 01Option Exercise8.2845,000372,375154,066Feb 02 06:32 PM
Patrick Charles WDirectorFeb 01Option Exercise8.2815,000124,12589,959Feb 02 06:22 PM
LANCASTER RONNY BDirectorFeb 01Option Exercise8.2815,000124,12578,603Feb 02 06:19 PM
Celano MichaelDirectorJan 31Option Exercise8.2815,000124,125108,079Feb 02 06:14 PM
Celano MichaelDirectorJan 31Sale8.7815,000131,70093,079Feb 02 06:14 PM
SPAIR RONALD HCOO & CFOJan 17Sale8.713,34129,103160,810Jan 19 05:02 PM
KUNA MARK LSVP & ControllerDec 15Option Exercise8.0610,00080,55082,965Dec 16 04:56 PM
KUNA MARK LSVP & ControllerDec 15Sale9.3010,00093,00072,965Dec 16 04:56 PM
Michels Douglas APresident & CEODec 13Option Exercise8.1071,466579,006803,364Dec 14 09:07 PM
KUNA MARK LSVP & ControllerDec 13Option Exercise8.2117,000139,57589,965Dec 14 09:09 PM
KUNA MARK LSVP & ControllerDec 13Sale9.1117,000154,85072,965Dec 14 09:09 PM
Michels Douglas APresident & CEODec 13Sale9.0771,466647,998731,898Dec 14 09:07 PM
KUNA MARK LSVP & ControllerDec 09Option Exercise8.283,00024,82575,965Dec 12 01:02 PM
Michels Douglas APresident & CEODec 09Option Exercise8.2823,891197,698755,789Dec 12 12:46 PM
KUNA MARK LSVP & ControllerDec 09Sale9.033,00027,09072,965Dec 12 01:02 PM
JERRETT JACK ESVP & General CounselNov 23Option Exercise8.1724,000195,96072,105Nov 25 05:53 PM
KUNA MARK LSVP & ControllerNov 23Option Exercise2.867,13120,42095,096Nov 25 05:55 PM
Michels Douglas APresident & CEONov 23Option Exercise8.285,89348,765737,791Nov 28 07:29 PM
Michels Douglas APresident & CEONov 23Sale9.0230,893278,711731,898Nov 28 07:29 PM
KUNA MARK LSVP & ControllerNov 23Sale9.027,13164,32272,965Nov 25 05:55 PM
JERRETT JACK ESVP & General CounselNov 23Sale9.0024,000216,00048,105Nov 25 05:53 PM
KUNA MARK LSVP & ControllerNov 22Option Exercise5.1915,00077,85087,965Nov 25 05:55 PM
KUNA MARK LSVP & ControllerNov 22Sale8.8815,000133,24580,096Nov 25 05:55 PM
Michels Douglas APresident & CEOSep 26Sale8.2225,000205,525756,898Sep 28 05:40 PM
Patrick Charles WDirectorAug 31Sale8.5817,483150,00414,905Aug 31 05:24 PM
JERRETT JACK ESVP & General CounselAug 30Option Exercise4.7936,415174,529116,791Aug 31 05:26 PM
JERRETT JACK ESVP & General CounselAug 30Sale8.5268,686585,42248,105Aug 31 05:26 PM
Patrick Charles WDirectorAug 29Sale8.942,25020,11574,959Aug 31 05:24 PM
Patrick Charles WDirectorAug 05Sale7.246,57547,60377,209Aug 31 05:24 PM